Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Ceridian HCM (CDAY) Financials

Ceridian HCM logo
Annual Income Statements for Ceridian HCM

Annual Income Statements for Ceridian HCM

This table shows Ceridian HCM's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
-93 3.30 -61 79 -4.00 -75 -73 55 18
Consolidated Net Income / (Loss)
-93 2.00 -61 79 -4.00 -75 -73 55 18
Net Income / (Loss) Continuing Operations
-105 8.00 -35 79 -4.00 -75 -73 55 18
Total Pre-Tax Income
-99 -41 -27 34 -20 -90 -63 96 38
Total Operating Income
-11 55 56 72 7.80 -36 -26 133 104
Total Gross Profit
227 270 315 368 341 382 473 647 812
Total Revenue
623 676 741 824 843 1,024 1,246 1,514 1,760
Operating Revenue
623 676 741 824 843 1,024 1,246 1,514 1,760
Total Cost of Revenue
396 407 426 456 501 642 773 867 948
Operating Cost of Revenue
396 407 426 456 501 642 773 867 948
Total Operating Expenses
238 214 259 296 334 418 499 513 708
Selling, General & Admin Expense
225 214 259 296 334 199 248 263 366
Marketing Expense
- - - - - 219 252 250 342
Total Other Income / (Expense), net
-87 -96 -83 -38 -28 -55 -37 -37 -67
Interest Expense
87 87 83 32 25 36 29 36 41
Other Income / (Expense), net
- -8.80 0.20 -5.60 -2.70 -19 -8.50 -1.00 -26
Income Tax Expense
6.70 -49 8.40 -44 -16 -15 11 41 20
Basic Earnings per Share
($1.65) ($0.26) ($0.60) $0.55 ($0.03) ($0.50) ($0.48) $0.35 $0.11
Weighted Average Basic Shares Outstanding
64.99M 65.20M 114.05M 142.05M 146.77M 150.40M 152.90M 155.30M 157.80M
Diluted Earnings per Share
($1.65) ($0.26) ($0.60) $0.53 ($0.03) ($0.50) ($0.48) $0.35 $0.11
Weighted Average Diluted Shares Outstanding
64.99M 65.20M 114.05M 148.76M 146.77M 150.40M 152.90M 158.50M 160.40M
Weighted Average Basic & Diluted Shares Outstanding
64.99M 65.20M 101M 143.10M 148.80M 152.05M 154.11M 156.60M 158.92M

Quarterly Income Statements for Ceridian HCM

This table shows Ceridian HCM's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Income / (Loss) Attributable to Common Shareholders
9.90 3.10 -3.80 46 7.10 -1.80 2.00 11 15 21 -197
Consolidated Net Income / (Loss)
9.90 3.10 -3.80 46 7.10 -1.80 2.00 11 15 21 -197
Net Income / (Loss) Continuing Operations
9.90 3.10 -3.80 46 7.10 -1.80 2.00 11 15 21 -197
Total Pre-Tax Income
28 20 13 36 18 0.00 18 0.90 19 38 -153
Total Operating Income
38 29 27 39 41 14 21 29 31 42 31
Total Gross Profit
160 156 161 170 343 334 353 219 383 372 386
Total Revenue
371 366 378 400 432 423 440 465 482 465 482
Operating Revenue
371 366 378 400 432 423 440 465 482 465 482
Total Cost of Revenue
210 210 217 230 88 89 87 247 98 93 96
Operating Cost of Revenue
210 210 217 230 88 89 87 247 98 93 96
Total Operating Expenses
122 127 134 131 302 320 332 190 352 330 356
Selling, General & Admin Expense
68 65 72 58 56 59 63 97 71 59 81
Marketing Expense
54 62 62 73 78 82 86 94 87 84 87
Research & Development Expense
- - - - 53 58 55 - 59 57 59
Depreciation Expense
- - - - 49 51 52 - 54 53 44
Other Operating Expenses / (Income)
- - - - 66 70 75 - 81 77 84
Total Other Income / (Expense), net
-10 -9.80 -14 -3.30 -22 -14 -2.50 -28 -12 -4.00 -183
Interest Expense
9.20 9.10 8.90 8.90 13 11 8.80 7.40 7.90 7.10 6.70
Other Income / (Expense), net
-0.80 -0.70 -5.10 5.60 -9.00 -3.00 6.30 -20 -4.00 3.10 -177
Income Tax Expense
19 17 16 -10 11 1.80 16 -9.90 4.20 17 44
Basic Earnings per Share
$0.06 $0.02 ($0.02) $0.29 $0.05 ($0.01) $0.01 $0.06 $0.09 $0.13 ($1.23)
Weighted Average Basic Shares Outstanding
154.20M 155.10M 155.70M 155.30M 156.90M 157.90M 158.10M 157.80M 159.40M 159.90M 159.80M
Diluted Earnings per Share
$0.06 $0.02 ($0.02) $0.29 $0.04 ($0.01) $0.01 $0.07 $0.09 $0.13 ($1.23)
Weighted Average Diluted Shares Outstanding
157.70M 157.60M 155.70M 158.50M 159.90M 157.90M 159.70M 160.40M 161.90M 161M 159.80M
Weighted Average Basic & Diluted Shares Outstanding
155.03M 155.61M 156.13M 156.60M 157.90M 158.10M 157.70M 158.92M 159.88M 159.69M 160.03M

Annual Cash Flow Statements for Ceridian HCM

This table details how cash moves in and out of Ceridian HCM's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
58 338 -1,293 552 570 -192 508 270 -168
Net Cash From Operating Activities
-76 -40 9.50 51 -30 49 133 220 281
Net Cash From Continuing Operating Activities
-73 -29 11 51 -30 49 133 220 281
Net Income / (Loss) Continuing Operations
-105 8.00 -35 79 -4.00 -75 -73 55 18
Consolidated Net Income / (Loss)
-93 2.00 -61 79 -4.00 -75 -73 55 18
Depreciation Expense
53 54 57 57 52 78 89 133 210
Amortization Expense
3.50 3.70 2.10 1.20 1.20 17 4.60 4.40 4.20
Non-Cash Adjustments To Reconcile Net Income
33 17 52 45 89 109 152 144 159
Changes in Operating Assets and Liabilities, net
-58 -112 -65 -131 -168 -79 -39 -116 -110
Net Cash From Investing Activities
763 -40 -51 -119 39 -711 -343 -203 -472
Net Cash From Continuing Investing Activities
724 -39 -51 -119 39 -711 -343 -203 -472
Purchase of Property, Plant & Equipment
-33 -18 -40 -55 -60 -64 -95 -114 -110
Acquisitions
- -0.50 0.00 -30 -58 -410 0.00 0.00 -173
Purchase of Investments
-700 -599 -855 -408 -212 -764 -653 -535 -557
Divestitures
102 - - 0.00 0.00 38 0.00 0.00 0.00
Sale and/or Maturity of Investments
678 610 844 375 369 488 405 448 368
Other Investing Activities, net
678 -33 - - - 0.00 0.00 -1.00 0.00
Net Cash From Financing Activities
-631 407 -1,252 610 565 492 765 242 60
Net Cash From Continuing Financing Activities
-593 407 -1,252 610 565 492 765 242 60
Repayment of Debt
-12 -26 -1,157 -7.20 -305 -304 -8.40 -7.90 -660
Repurchase of Common Equity
- -1.80 - - - - 0.00 0.00 -36
Issuance of Debt
- 0.00 680 0.00 295 857 0.00 0.00 650
Issuance of Common Equity
75 78 641 87 92 95 38 49 57
Other Financing Activities, net
-656 356 -1,415 530 484 -156 735 201 49
Other Net Changes in Cash
1.30 - - - - -21 -47 - -36
Cash Interest Paid
85 90 75 37 27 19 30 52 45
Cash Income Taxes Paid
15 21 21 36 4.20 33 18 43 56

Quarterly Cash Flow Statements for Ceridian HCM

This table details how cash moves in and out of Ceridian HCM's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Net Change in Cash & Equivalents
2,190 -1,900 175 -195 1,478 -1,767 -1,055 1,176 219 -1,132 103
Net Cash From Operating Activities
11 82 37 90 9.10 99 92 81 50 113 31
Net Cash From Continuing Operating Activities
11 82 37 90 9.10 99 92 81 50 113 31
Net Income / (Loss) Continuing Operations
9.90 3.10 -3.80 46 7.10 -1.80 2.00 11 15 21 -197
Consolidated Net Income / (Loss)
9.90 3.10 -3.80 46 7.10 -1.80 2.00 11 15 21 -197
Depreciation Expense
22 23 39 48 49 51 52 58 54 53 44
Amortization Expense
1.10 1.10 1.10 1.10 1.10 1.00 1.10 1.00 1.10 1.10 1.20
Non-Cash Adjustments To Reconcile Net Income
44 42 38 21 46 46 21 46 54 54 226
Changes in Operating Assets and Liabilities, net
-65 13 -38 -26 -94 3.10 16 -35 -75 -17 -43
Net Cash From Investing Activities
-1.40 16 -30 -188 -291 -93 -75 -14 -120 -60 -112
Net Cash From Continuing Investing Activities
-1.40 16 -30 -188 -291 -93 -75 -14 -120 -60 -112
Purchase of Property, Plant & Equipment
-28 -28 -32 -26 -28 -27 -28 -27 -30 -26 -26
Acquisitions
0.00 - - - -173 0.20 - - 0.00 - -5.50
Purchase of Investments
-73 -29 -150 -283 -140 -187 -166 -64 -184 -183 -193
Sale and/or Maturity of Investments
101 74 152 121 51 120 120 77 94 149 112
Net Cash From Financing Activities
2,187 -2,068 226 -103 1,773 -1,765 -1,075 1,127 289 -1,208 197
Net Cash From Continuing Financing Activities
2,187 -2,068 226 -103 1,773 -1,765 -1,075 1,127 289 -1,208 197
Repayment of Debt
-2.10 -2.00 -1.90 -1.90 -656 -0.20 -1.80 -1.80 -3.00 -1.80 -1.90
Repurchase of Common Equity
- - - - 0.00 - - -7.30 -30 -21 -9.00
Issuance of Common Equity
15 8.40 17 8.70 22 1.50 5.20 35 4.40 4.50 14
Other Financing Activities, net
2,174 -2,074 211 -110 1,757 -1,767 -1,050 1,102 317 -1,190 194

Annual Balance Sheets for Ceridian HCM

This table presents Ceridian HCM's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
6,730 5,248 6,086 6,701 7,166 8,464 9,011 9,117
Total Current Assets
4,458 2,934 3,624 4,123 4,144 5,440 5,955 5,984
Cash & Equivalents
94 218 281 188 368 432 570 580
Restricted Cash
4,100 2,604 3,204 3,759 3,536 4,730 5,029 5,002
Accounts Receivable
67 64 80 101 146 180 229 265
Prepaid Expenses
36 49 58 74 93 98 127 138
Plant, Property, & Equipment, net
102 104 128 136 128 175 210 224
Total Noncurrent Assets
2,170 2,209 2,334 2,442 2,894 2,848 2,846 2,910
Goodwill
1,961 1,927 1,974 2,032 2,324 2,280 2,294 2,337
Intangible Assets
207 188 178 195 333 282 230 189
Other Noncurrent Operating Assets
2.00 94 182 216 238 287 322 384
Total Liabilities & Shareholders' Equity
6,730 5,248 6,086 6,701 7,166 8,464 9,011 9,117
Total Liabilities
5,601 3,632 4,203 4,603 4,939 6,354 6,613 6,571
Total Current Liabilities
4,283 2,770 3,363 3,864 211 5,080 5,335 5,315
Short-Term Debt
- 6.80 11 7.20 8.30 7.80 7.60 7.30
Accounts Payable
44 42 43 39 52 54 67 77
Accrued Expenses
15 24 14 21 25 24 30 32
Customer Deposits
- - - 3,698 - 4,845 5,090 5,024
Current Deferred Revenue
14 23 26 24 49 41 40 42
Current Employee Benefit Liabilities
69 55 76 65 77 97 93 127
Total Noncurrent Liabilities
1,318 863 841 750 4,728 1,274 1,285 1,262
Long-Term Debt
1,120 664 666 661 1,124 1,213 1,210 1,209
Capital Lease Obligations
- 0.00 8.80 11 11 - 7.00 5.70
Noncurrent Employee Benefit Liabilities
152 153 117 24 21 18 28 5.90
Other Noncurrent Operating Liabilities
46 46 48 54 3,572 43 40 41
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,129 1,616 1,882 2,098 2,228 2,109 2,398 2,546
Total Preferred & Common Equity
1,091 1,616 1,882 2,098 2,228 2,109 2,398 2,546
Total Common Equity
906 1,616 1,882 2,098 2,228 2,109 2,398 2,546
Common Stock
1,566 2,327 2,451 2,608 2,862 2,967 3,153 3,365
Retained Earnings
-348 -336 -230 -234 -309 -373 -318 -336
Accumulated Other Comprehensive Income / (Loss)
-312 -376 -338 -276 -325 -485 -437 -483

Quarterly Balance Sheets for Ceridian HCM

This table presents Ceridian HCM's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Total Assets
10,062 8,119 8,943 9,011 10,775 9,046 8,117 9,117 9,500 8,501 8,676
Total Current Assets
7,042 5,067 5,915 5,955 7,555 5,837 4,904 5,984 6,358 5,314 5,532
Cash & Equivalents
429 487 510 570 393 465 494 580 557 625 628
Restricted Cash
6,285 4,263 5,049 5,029 6,747 4,970 4,001 5,002 5,363 4,260 4,434
Accounts Receivable
205 205 236 229 276 261 256 265 294 271 325
Prepaid Expenses
122 113 119 127 140 140 153 138 144 158 145
Plant, Property, & Equipment, net
186 198 211 210 215 220 228 224 229 237 233
Total Noncurrent Assets
2,834 2,853 2,818 2,846 3,005 2,990 2,985 2,910 2,913 2,950 2,912
Goodwill
2,281 2,288 2,271 2,294 2,386 2,383 2,395 2,337 2,343 2,383 2,385
Intangible Assets
275 268 245 230 287 256 228 189 162 143 130
Other Noncurrent Operating Assets
278 298 302 322 332 350 362 384 407 424 398
Total Liabilities & Shareholders' Equity
10,062 8,119 8,943 9,011 10,775 9,046 8,117 9,117 9,500 8,501 8,676
Total Liabilities
7,867 5,879 6,676 6,613 8,342 6,570 5,561 6,571 6,907 5,799 5,982
Total Current Liabilities
205 4,604 5,412 5,335 7,049 5,280 4,278 5,315 6,226 5,118 5,302
Short-Term Debt
7.70 7.60 7.50 7.60 5.60 7.30 7.30 7.30 582 582 582
Accounts Payable
61 65 67 67 69 66 73 77 86 85 89
Accrued Expenses
31 36 42 30 42 42 66 32 36 26 61
Customer Deposits
- 4,374 5,166 5,090 6,816 5,032 4,005 5,024 5,362 4,250 4,413
Current Deferred Revenue
47 44 48 40 46 47 43 42 40 47 39
Current Employee Benefit Liabilities
58 71 76 93 64 80 78 127 114 121 112
Total Noncurrent Liabilities
7,662 1,282 1,272 1,285 1,300 1,296 1,289 1,262 687 687 685
Long-Term Debt
1,212 1,212 1,211 1,210 1,212 1,211 1,210 1,209 632 632 631
Capital Lease Obligations
7.70 7.30 6.90 7.00 6.40 5.90 6.00 5.70 6.00 6.10 5.60
Noncurrent Employee Benefit Liabilities
16 14 12 28 27 26 25 5.90 5.60 5.30 4.80
Other Noncurrent Operating Liabilities
6,426 49 42 40 55 53 48 41 43 44 44
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,194 2,240 2,267 2,398 2,433 2,476 2,556 2,546 2,592 2,702 2,695
Total Preferred & Common Equity
2,194 2,240 2,267 2,398 2,433 2,476 2,556 2,546 2,592 2,702 2,695
Total Common Equity
2,194 2,240 2,267 2,398 2,433 2,476 2,556 2,546 2,592 2,702 2,695
Common Stock
3,022 3,072 3,125 3,153 3,206 3,248 3,293 3,365 3,393 3,439 3,492
Retained Earnings
-363 -360 -363 -318 -311 -313 -341 -336 -351 -351 -556
Accumulated Other Comprehensive Income / (Loss)
-465 -472 -495 -437 -463 -460 -397 -483 -450 -386 -241

Annual Metrics And Ratios for Ceridian HCM

This table displays calculated financial ratios and metrics derived from Ceridian HCM's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 8.47% 9.54% 11.26% 2.23% 21.57% 21.68% 21.47% 16.27%
EBITDA Growth
0.00% 128.79% 10.47% 8.70% -53.52% -31.15% 48.25% 353.63% 8.62%
EBIT Growth
0.00% 516.07% 20.82% 18.47% -92.35% -1,166.67% 36.95% 485.13% -40.80%
NOPAT Growth
0.00% 594.64% 1.26% 322.43% -96.71% -555.13% 27.32% 520.70% -34.04%
Net Income Growth
0.00% 102.16% -3,155.00% 228.81% -105.08% -1,785.00% 2.65% 174.66% -66.97%
EPS Growth
0.00% 84.24% -130.77% 188.33% -105.66% -1,566.67% 4.00% 172.92% -68.57%
Operating Cash Flow Growth
0.00% 47.28% 123.87% 432.63% -159.68% 261.59% 171.72% 65.54% 28.06%
Free Cash Flow Firm Growth
0.00% 0.00% -170.85% 136.73% -52.64% -355.34% 293.26% -82.72% -151.49%
Invested Capital Growth
0.00% 0.00% 74.08% -71.28% -27.68% 54.43% -243.19% -7.93% 8.30%
Revenue Q/Q Growth
0.00% 0.00% 3.73% 3.39% 0.12% 6.15% 4.53% 4.39% 3.87%
EBITDA Q/Q Growth
0.00% 0.00% -11.20% -1.42% -40.23% 308.16% 17.66% 29.64% -8.26%
EBIT Q/Q Growth
0.00% 0.00% -19.69% -1.48% -88.86% 28.61% 15.52% 40.68% -31.58%
NOPAT Q/Q Growth
0.00% 0.00% -19.97% -13.93% -82.02% 40.83% 2.64% 1,028.77% -40.21%
Net Income Q/Q Growth
0.00% 0.00% -2,445.83% 0.77% -133.90% 9.38% 5.53% 1,270.00% -65.78%
EPS Q/Q Growth
0.00% 0.00% -433.33% -5.36% 0.00% 0.00% 5.88% 1,066.67% -66.67%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 39.71% -3.07% -141.20% 270.63% 46.20% 28.06% -3.07%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 163.04% 312.00% -130.55% 233.07% -64.18% 91.02%
Invested Capital Q/Q Growth
0.00% 0.00% 61.85% -167.87% -517.34% 77.76% -25.78% 4.36% -153.33%
Profitability Metrics
- - - - - - - - -
Gross Margin
36.41% 39.86% 42.51% 44.68% 40.51% 37.33% 37.97% 42.71% 46.14%
EBITDA Margin
7.30% 15.39% 15.53% 15.17% 6.90% 3.91% 4.76% 17.77% 16.60%
Operating Margin
-1.80% 8.19% 7.57% 8.77% 0.93% -3.47% -2.07% 8.79% 5.91%
EBIT Margin
-1.80% 6.89% 7.60% 8.09% 0.61% -5.31% -2.75% 8.73% 4.44%
Profit (Net Income) Margin
-14.89% 0.30% -8.25% 9.55% -0.47% -7.36% -5.89% 3.62% 1.03%
Tax Burden Percent
94.12% -4.94% 227.14% 229.45% 20.00% 83.50% 116.69% 57.08% 48.14%
Interest Burden Percent
880.36% -86.91% -47.78% 51.42% -392.16% 165.99% 183.38% 72.67% 48.08%
Effective Tax Rate
0.00% 0.00% 0.00% -129.45% 0.00% 0.00% 0.00% 42.92% 51.86%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
0.00% 0.18% -4.45% 4.50% -0.20% -3.49% -3.38% 2.43% 0.73%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.69% 0.94% 1.18% 0.08% -0.78% -0.44% 1.51% 0.86%
Return on Assets (ROA)
0.00% 0.03% -1.02% 1.39% -0.06% -1.09% -0.94% 0.63% 0.20%
Return on Common Equity (ROCE)
0.00% 0.14% -4.09% 4.50% -0.20% -3.49% -3.38% 2.43% 0.73%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.18% -3.78% 4.18% -0.19% -3.39% -3.48% 2.29% 0.71%
Net Operating Profit after Tax (NOPAT)
-7.84 39 39 166 5.46 -25 -18 76 50
NOPAT Margin
-1.26% 5.74% 5.30% 20.13% 0.65% -2.43% -1.45% 5.02% 2.85%
Net Nonoperating Expense Percent (NNEP)
0.00% -2.30% -3.76% -3.52% -0.31% -1.68% -1.65% -0.51% -0.73%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - -0.54% 2.10% 1.33%
Cost of Revenue to Revenue
63.59% 60.14% 57.49% 55.32% 59.49% 62.67% 62.03% 57.29% 53.86%
SG&A Expenses to Revenue
36.14% 31.66% 34.94% 35.91% 39.58% 19.46% 19.86% 17.39% 20.80%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
38.21% 31.66% 34.94% 35.91% 39.58% 40.79% 40.04% 33.92% 40.23%
Earnings before Interest and Taxes (EBIT)
-11 47 56 67 5.10 -54 -34 132 78
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
46 104 115 125 58 40 59 269 292
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.51 2.95 5.19 7.51 7.10 4.67 4.37 4.50
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 561.54
Price to Revenue (P/Rev)
0.74 0.68 6.43 11.85 18.69 15.43 7.91 6.92 6.51
Price to Earnings (P/E)
0.00 140.00 0.00 124.10 0.00 0.00 0.00 191.23 632.89
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.71% 0.00% 0.81% 0.00% 0.00% 0.00% 0.52% 0.16%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 3.52 8.45 14.81 12.74 4.74 4.03 4.03
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 22.70 55.74 214.81 326.22 99.70 22.69 24.29
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 46.37 104.46 2,447.17 0.00 0.00 46.21 90.74
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 66.48 42.00 2,285.82 0.00 0.00 80.34 141.61
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 274.79 137.69 0.00 267.39 44.59 27.81 25.24
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 12.72 48.12 0.00 4.62 27.60 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 0.99 0.41 0.36 0.32 0.51 0.58 0.51 0.48
Long-Term Debt to Equity
0.00 0.99 0.41 0.36 0.32 0.51 0.58 0.51 0.48
Financial Leverage
0.00 -2.83 -1.95 -1.42 -1.52 -1.39 -1.55 -1.84 -1.77
Leverage Ratio
0.00 5.96 4.36 3.24 3.21 3.21 3.60 3.88 3.67
Compound Leverage Factor
0.00 -5.18 -2.09 1.67 -12.60 5.32 6.61 2.82 1.76
Debt to Total Capital
0.00% 49.80% 29.32% 26.71% 24.43% 33.93% 36.67% 33.80% 32.43%
Short-Term Debt to Total Capital
0.00% 0.00% 0.30% 0.42% 0.26% 0.25% 0.23% 0.21% 0.19%
Long-Term Debt to Total Capital
0.00% 49.80% 29.03% 26.29% 24.17% 33.69% 36.43% 33.59% 32.24%
Preferred Equity to Total Capital
0.00% 8.24% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 1.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 40.28% 70.68% 73.29% 75.57% 66.07% 63.33% 66.20% 67.57%
Debt to EBITDA
0.00 10.76 5.83 5.49 11.67 28.60 20.59 4.55 4.18
Net Debt to EBITDA
0.00 -29.53 -18.70 -22.40 -56.27 -68.98 -66.46 -16.26 -14.92
Long-Term Debt to EBITDA
0.00 10.76 5.77 5.40 11.55 28.39 20.46 4.52 4.16
Debt to NOPAT
0.00 28.88 17.07 4.13 124.23 -46.04 -67.62 16.12 24.39
Net Debt to NOPAT
0.00 -79.27 -54.77 -16.88 -598.77 111.04 218.22 -57.58 -86.99
Long-Term Debt to NOPAT
0.00 28.88 16.90 4.07 122.91 -45.70 -67.19 16.02 24.24
Altman Z-Score
0.00 0.13 0.91 1.56 2.18 2.64 1.05 1.20 1.30
Noncontrolling Interest Sharing Ratio
0.00% 19.77% 8.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 1.04 1.06 1.08 1.07 19.67 1.07 1.12 1.13
Quick Ratio
0.00 0.04 0.10 0.11 0.07 2.44 0.12 0.15 0.16
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 2,105 -1,491 548 259 -662 1,280 221 -114
Operating Cash Flow to CapEx
-229.48% -227.43% 23.63% 91.67% -50.50% 76.61% 140.32% 191.87% 256.48%
Free Cash Flow to Firm to Interest Expense
0.00 24.16 -17.92 16.90 10.33 -18.45 44.75 6.13 -2.81
Operating Cash Flow to Interest Expense
-0.86 -0.46 0.11 1.56 -1.20 1.36 4.64 6.08 6.92
Operating Cash Flow Less CapEx to Interest Expense
-1.24 -0.66 -0.37 -0.14 -3.59 -0.42 1.33 2.91 4.22
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 0.10 0.12 0.15 0.13 0.15 0.16 0.17 0.19
Accounts Receivable Turnover
0.00 10.15 11.35 11.42 9.28 8.28 7.64 7.40 7.13
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 6.63 7.18 7.08 6.37 7.74 8.22 7.86 8.11
Accounts Payable Turnover
0.00 9.16 9.91 10.77 12.21 14.17 14.58 14.33 13.19
Days Sales Outstanding (DSO)
0.00 35.95 32.15 31.96 39.32 44.08 47.80 49.30 51.18
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 39.85 36.82 33.91 29.89 25.76 25.03 25.46 27.67
Cash Conversion Cycle (CCC)
0.00 -3.90 -4.66 -1.95 9.42 18.33 22.77 23.84 23.52
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 -2,066 -536 -917 -1,171 -534 -1,832 -1,977 -1,813
Invested Capital Turnover
0.00 -0.65 -0.57 -1.13 -0.81 -1.20 -1.05 -0.79 -0.93
Increase / (Decrease) in Invested Capital
0.00 -2,066 1,530 -382 -254 637 -1,298 -145 164
Enterprise Value (EV)
0.00 -2,389 2,610 6,967 12,481 13,049 5,912 6,104 7,096
Market Capitalization
462 462 4,761 9,767 15,750 15,808 9,853 10,479 11,455
Book Value per Share
$0.00 $13.89 $11.70 $13.08 $14.20 $14.72 $13.73 $15.36 $16.15
Tangible Book Value per Share
$0.00 ($19.35) ($3.62) ($1.87) ($0.87) ($2.83) ($2.94) ($0.81) $0.13
Total Capital
0.00 2,249 2,286 2,568 2,777 3,372 3,331 3,623 3,768
Total Debt
0.00 1,120 670 686 678 1,144 1,221 1,225 1,222
Total Long-Term Debt
0.00 1,120 664 675 671 1,136 1,213 1,217 1,215
Net Debt
0.00 -3,074 -2,151 -2,800 -3,269 -2,759 -3,941 -4,375 -4,359
Capital Expenditures (CapEx)
33 18 40 55 60 64 95 114 110
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 -4,019 -2,650 -3,214 -3,682 38 -4,794 -4,972 -4,905
Debt-free Net Working Capital (DFNWC)
0.00 175 171 272 266 3,942 368 628 676
Net Working Capital (NWC)
0.00 175 165 261 259 3,933 361 620 669
Net Nonoperating Expense (NNE)
85 37 100 87 9.46 51 55 21 32
Net Nonoperating Obligations (NNO)
0.00 -3,195 -2,151 -2,800 -3,269 -2,761 -3,941 -4,375 -4,359
Total Depreciation and Amortization (D&A)
57 58 59 58 53 94 94 137 214
Debt-free, Cash-free Net Working Capital to Revenue
0.00% -594.31% -357.77% -389.98% -437.00% 3.75% -384.68% -328.45% -278.70%
Debt-free Net Working Capital to Revenue
0.00% 25.91% 23.13% 32.96% 31.56% 384.86% 29.55% 41.48% 38.41%
Net Working Capital to Revenue
0.00% 25.91% 22.21% 31.65% 30.71% 384.05% 28.93% 40.98% 37.99%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
($1.65) ($0.46) ($0.62) $0.55 ($0.03) ($0.50) ($0.48) $0.35 $0.11
Adjusted Weighted Average Basic Shares Outstanding
64.99M 65.20M 140.51M 142.05M 146.77M 150.40M 152.94M 155.30M 157.80M
Adjusted Diluted Earnings per Share
($1.65) ($0.46) ($0.62) $0.53 ($0.03) ($0.50) ($0.48) $0.35 $0.11
Adjusted Weighted Average Diluted Shares Outstanding
64.99M 65.20M 140.51M 148.76M 146.77M 150.40M 152.94M 158.50M 160.40M
Adjusted Basic & Diluted Earnings per Share
($1.65) ($0.46) ($0.62) $0.55 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
64.99M 65.20M 114.05M 144.71M 148.80M 152.05M 154.11M 156.60M 158.92M
Normalized Net Operating Profit after Tax (NOPAT)
-7.84 39 39 51 5.46 -25 -18 76 73
Normalized NOPAT Margin
-1.26% 5.74% 5.30% 6.14% 0.65% -2.43% -1.45% 5.02% 4.14%
Pre Tax Income Margin
-15.82% -5.99% -3.63% 4.16% -2.37% -8.82% -5.05% 6.34% 2.14%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
-0.13 0.54 0.68 2.06 0.20 -1.52 -1.20 3.66 1.93
NOPAT to Interest Expense
-0.09 0.45 0.47 5.12 0.22 -0.69 -0.63 2.10 1.23
EBIT Less CapEx to Interest Expense
-0.50 0.33 0.19 0.35 -2.18 -3.29 -4.50 0.49 -0.77
NOPAT Less CapEx to Interest Expense
-0.47 0.24 -0.01 3.42 -2.16 -2.47 -3.94 -1.06 -1.47
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 90.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 199.45%

Quarterly Metrics And Ratios for Ceridian HCM

This table displays calculated financial ratios and metrics derived from Ceridian HCM's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
26.36% 21.48% 19.61% 18.92% 16.43% 15.69% 16.56% 16.39% 11.66% 9.78% 9.45%
EBITDA Growth
1,742.42% 415.53% 360.15% 189.81% 34.21% 18.08% 31.21% -28.01% 0.49% 59.01% -225.40%
EBIT Growth
302.15% 333.33% 322.92% 616.13% -15.69% -61.32% 26.64% -81.31% -14.83% 309.01% -639.48%
NOPAT Growth
201.18% 202.20% -211.04% 2,057.53% 17.32% 112.26% 128.22% 586.21% 53.99% 138.34% 839.19%
Net Income Growth
136.13% 115.66% 81.90% 976.92% -28.28% -158.06% 152.63% -76.32% 109.86% 1,283.33% -9,940.00%
EPS Growth
133.33% 115.38% 85.71% 1,066.67% -33.33% -150.00% 150.00% -75.86% 125.00% 1,400.00% -12,400.00%
Operating Cash Flow Growth
105.45% 146.08% -29.75% 115.07% -19.47% 21.42% 150.82% -9.90% 445.05% 13.61% -66.01%
Free Cash Flow Firm Growth
-136.83% -151.95% 163.73% -85.00% 119.88% 140.19% -323.83% -8.74% -754.81% -261.88% 133.61%
Invested Capital Growth
24.21% 47.45% -41.94% -7.93% -5.79% -35.37% 65.38% 8.30% 39.51% 44.57% -60.38%
Revenue Q/Q Growth
10.26% -1.27% 3.17% 5.88% 7.96% -1.90% 3.95% 5.73% 3.57% -3.55% 3.64%
EBITDA Q/Q Growth
87.65% -12.66% 15.25% 53.43% -13.10% -23.16% 28.07% -15.82% 21.30% 21.59% -201.00%
EBIT Q/Q Growth
506.45% -23.67% -25.44% 107.48% -28.60% -64.98% 144.14% -69.37% 225.30% 68.15% -422.03%
NOPAT Q/Q Growth
479.48% -65.26% -273.25% 718.66% -68.49% -37.15% -76.97% 14,944.71% -92.93% -2.72% -9.24%
Net Income Q/Q Growth
290.38% -68.69% -222.58% 1,300.00% -84.43% -125.35% 211.11% 440.00% 37.96% 42.95% -1,023.94%
EPS Q/Q Growth
300.00% -66.67% -200.00% 1,550.00% -86.21% -125.00% 200.00% 600.00% 28.57% 44.44% -1,046.15%
Operating Cash Flow Q/Q Growth
-72.97% 623.01% -55.20% 145.63% -89.88% 990.11% -7.46% -11.76% -38.77% 127.22% -72.32%
Free Cash Flow Firm Q/Q Growth
-179.89% -11.03% 152.26% -67.64% 5.88% 124.44% -391.09% 113.19% -859.67% 44.52% 160.44%
Invested Capital Q/Q Growth
-79.78% 61.05% -61.18% 4.36% -76.22% 50.17% 58.78% -153.33% -16.24% 54.34% -19.28%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
43.25% 42.61% 42.52% 42.48% 47.60% 44.13% 45.75% 46.99% 79.58% 80.05% 80.15%
EBITDA Margin
16.41% 14.51% 16.21% 23.49% 18.91% 14.81% 18.25% 14.53% 17.02% 21.45% -20.91%
Operating Margin
10.36% 8.04% 7.02% 9.71% 9.43% 3.33% 4.73% 6.13% 6.43% 9.10% 6.33%
EBIT Margin
10.15% 7.84% 5.67% 11.11% 7.35% 2.62% 6.16% 1.78% 5.60% 9.77% -30.36%
Profit (Net Income) Margin
2.67% 0.85% -1.01% 11.41% 1.65% -0.43% 0.45% 2.32% 3.09% 4.58% -40.86%
Tax Burden Percent
34.86% 15.82% -30.40% 128.45% 38.59% 0.00% 10.93% 1,200.00% 78.01% 55.61% 128.71%
Interest Burden Percent
75.53% 68.29% 58.41% 79.96% 58.04% 0.00% 67.53% 10.84% 70.74% 84.36% 104.58%
Effective Tax Rate
65.14% 84.18% 130.40% -28.45% 61.41% 0.00% 89.07% -1,100.00% 21.99% 44.39% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)
-1.67% -0.61% 0.19% 2.43% 2.25% 2.00% 2.19% 0.73% 1.03% 1.89% -5.71%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
1.27% 1.27% 0.97% 1.92% 1.11% 0.50% 1.22% 0.35% 1.00% 2.06% -6.85%
Return on Assets (ROA)
0.33% 0.14% -0.17% 1.98% 0.25% -0.08% 0.09% 0.45% 0.55% 0.97% -9.21%
Return on Common Equity (ROCE)
-1.67% -0.61% 0.19% 2.43% 2.25% 2.00% 2.19% 0.73% 1.03% 1.89% -5.71%
Return on Equity Simple (ROE_SIMPLE)
-1.65% -0.59% 0.18% 0.00% 2.14% 1.90% 2.07% 0.00% 1.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
13 4.65 -8.06 50 16 9.87 2.27 342 24 24 21
NOPAT Margin
3.61% 1.27% -2.13% 12.47% 3.64% 2.33% 0.52% 73.52% 5.02% 5.06% 4.43%
Net Nonoperating Expense Percent (NNEP)
-0.06% -0.04% 0.11% -0.10% -0.15% -0.30% -0.01% -7.58% -0.17% -0.06% -6.13%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.38% - - - 9.08% 0.63% 0.60% 0.55%
Cost of Revenue to Revenue
56.75% 57.39% 57.48% 57.52% 52.40% 55.87% 54.25% 53.01% 20.42% 19.95% 19.85%
SG&A Expenses to Revenue
18.27% 17.76% 19.13% 14.59% 19.86% 21.17% 21.39% 20.77% 14.76% 12.67% 16.86%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.31% 12.33% 12.31%
Operating Expenses to Revenue
32.89% 34.57% 35.50% 32.77% 38.17% 40.80% 41.02% 40.86% 73.14% 70.95% 73.82%
Earnings before Interest and Taxes (EBIT)
38 29 21 44 32 11 27 8.30 27 45 -146
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
61 53 61 94 82 63 80 68 82 100 -101
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
5.14 4.63 4.66 4.37 4.25 3.16 3.79 4.50 3.58 3.28 4.08
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 561.54 107.41 50.06 61.05
Price to Revenue (P/Rev)
8.53 7.48 7.28 6.92 6.56 4.80 5.71 6.51 5.12 4.78 5.81
Price to Earnings (P/E)
0.00 0.00 2,639.58 191.23 198.79 166.28 183.06 632.89 357.91 180.73 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.04% 0.52% 0.50% 0.60% 0.55% 0.16% 0.28% 0.55% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)
4.38 4.94 4.29 4.03 2.81 2.22 3.78 4.03 2.52 2.80 3.78
Enterprise Value to EBITDA (EV/EBITDA)
49.64 42.98 30.00 22.69 15.25 12.09 20.13 24.29 15.62 15.75 48.18
Enterprise Value to EBIT (EV/EBIT)
264.73 109.06 66.29 46.21 35.03 33.33 56.10 90.74 62.19 48.16 0.00
Enterprise Value to NOPAT (EV/NOPAT)
262.92 0.00 924.73 80.34 54.00 42.49 76.50 141.61 71.60 66.19 77.30
Enterprise Value to Operating Cash Flow (EV/OCF)
41.89 36.70 36.32 27.81 20.34 15.42 22.11 25.24 14.21 15.49 26.08
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 10.08 27.60 16.21 6.72 0.00 0.00 0.00 0.00 13.64
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.56 0.55 0.54 0.51 0.50 0.49 0.48 0.48 0.47 0.45 0.45
Long-Term Debt to Equity
0.56 0.54 0.54 0.51 0.50 0.49 0.48 0.48 0.25 0.24 0.24
Financial Leverage
-2.76 -1.86 -1.82 -1.84 -2.46 -1.64 -1.58 -1.77 -2.11 -1.52 -1.35
Leverage Ratio
4.87 3.97 3.93 3.88 4.50 3.64 3.54 3.67 4.03 3.39 3.20
Compound Leverage Factor
3.68 2.71 2.29 3.10 2.61 0.00 2.39 0.40 2.85 2.86 3.34
Debt to Total Capital
35.88% 35.38% 35.09% 33.80% 33.46% 33.08% 32.37% 32.43% 32.02% 31.11% 31.15%
Short-Term Debt to Total Capital
0.23% 0.22% 0.21% 0.21% 0.15% 0.20% 0.19% 0.19% 15.27% 14.85% 14.88%
Long-Term Debt to Total Capital
35.65% 35.16% 34.87% 33.59% 33.31% 32.88% 32.17% 32.24% 16.74% 16.26% 16.27%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
64.12% 64.62% 64.91% 66.20% 66.54% 66.92% 67.63% 67.57% 67.98% 68.89% 68.85%
Debt to EBITDA
10.51 7.69 5.91 4.55 4.22 4.09 3.84 4.18 4.17 3.70 8.20
Net Debt to EBITDA
-46.97 -22.07 -20.89 -16.26 -20.42 -14.07 -10.27 -14.92 -16.06 -11.12 -25.86
Long-Term Debt to EBITDA
10.45 7.64 5.87 4.52 4.20 4.06 3.82 4.16 2.18 1.94 4.28
Debt to NOPAT
55.68 -39.29 182.04 16.12 14.94 14.37 14.59 24.39 19.12 15.56 13.16
Net Debt to NOPAT
-248.81 112.84 -643.87 -57.58 -72.27 -49.44 -39.03 -86.99 -73.61 -46.73 -41.49
Long-Term Debt to NOPAT
55.33 -39.05 180.92 16.02 14.88 14.28 14.51 24.24 10.00 8.13 6.88
Altman Z-Score
1.77 1.25 1.13 1.17 0.92 0.93 1.30 1.28 0.97 1.12 1.21
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
34.30 1.10 1.09 1.12 1.07 1.11 1.15 1.13 1.02 1.04 1.04
Quick Ratio
3.08 0.15 0.14 0.15 0.09 0.14 0.18 0.16 0.14 0.18 0.18
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-1,039 -1,153 603 195 207 463 -1,349 178 -1,352 -750 453
Operating Cash Flow to CapEx
39.79% 290.75% 115.09% 344.44% 32.62% 374.34% 323.24% 302.24% 164.78% 440.23% 119.08%
Free Cash Flow to Firm to Interest Expense
-112.90 -126.73 67.72 21.91 15.53 41.75 -153.31 24.05 -171.17 -105.67 67.68
Operating Cash Flow to Interest Expense
1.23 8.98 4.11 10.10 0.68 8.94 10.43 10.95 6.28 15.87 4.66
Operating Cash Flow Less CapEx to Interest Expense
-1.86 5.89 0.54 7.17 -1.41 6.55 7.20 7.32 2.47 12.27 0.75
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.13 0.16 0.17 0.17 0.15 0.19 0.20 0.19 0.18 0.21 0.23
Accounts Receivable Turnover
7.58 7.78 7.40 7.40 6.55 7.00 6.89 7.13 6.35 6.96 6.52
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
8.28 8.17 8.15 7.86 7.86 7.80 7.71 8.11 8.16 8.11 8.22
Accounts Payable Turnover
14.35 14.07 13.61 14.33 13.55 13.82 13.34 13.19 12.34 12.70 11.97
Days Sales Outstanding (DSO)
48.14 46.91 49.30 49.30 55.70 52.12 53.00 51.18 57.50 52.43 55.99
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
25.43 25.95 26.82 25.46 26.93 26.41 27.36 27.67 29.57 28.74 30.50
Cash Conversion Cycle (CCC)
22.71 20.96 22.48 23.84 28.77 25.72 25.64 23.52 27.93 23.69 25.50
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
-3,293 -1,282 -2,067 -1,977 -3,484 -1,736 -716 -1,813 -2,107 -962 -1,148
Invested Capital Turnover
-0.35 -0.75 -0.82 -0.79 -0.46 -1.08 -1.22 -0.93 -0.65 -1.37 -2.03
Increase / (Decrease) in Invested Capital
1,052 1,158 -611 -145 -191 -454 1,351 164 1,376 774 -432
Enterprise Value (EV)
5,797 6,860 6,224 6,104 4,421 3,620 6,412 7,096 4,571 5,191 7,159
Market Capitalization
11,284 10,382 10,558 10,479 10,337 7,832 9,684 11,455 9,270 8,856 11,001
Book Value per Share
$14.24 $14.45 $14.57 $15.36 $15.51 $15.68 $16.17 $16.15 $16.31 $16.90 $16.87
Tangible Book Value per Share
($2.35) ($2.04) ($1.60) ($0.81) ($1.53) ($1.04) ($0.42) $0.13 $0.54 $1.11 $1.13
Total Capital
3,422 3,467 3,492 3,623 3,656 3,700 3,779 3,768 3,813 3,923 3,914
Total Debt
1,228 1,227 1,225 1,225 1,224 1,224 1,223 1,222 1,221 1,220 1,219
Total Long-Term Debt
1,220 1,219 1,218 1,217 1,218 1,217 1,216 1,215 638 638 637
Net Debt
-5,486 -3,523 -4,334 -4,375 -5,916 -4,212 -3,272 -4,359 -4,699 -3,665 -3,842
Capital Expenditures (CapEx)
28 28 32 26 28 27 28 27 30 26 26
Debt-free, Cash-free Net Working Capital (DFCFNWC)
130 -4,279 -5,049 -4,972 -6,628 -4,872 -3,862 -4,905 -5,206 -4,106 -4,250
Debt-free Net Working Capital (DFNWC)
6,844 471 511 628 512 564 633 676 714 779 812
Net Working Capital (NWC)
6,836 463 503 620 506 556 626 669 132 197 230
Net Nonoperating Expense (NNE)
3.49 1.55 -4.26 4.24 8.60 12 0.27 331 9.28 2.22 218
Net Nonoperating Obligations (NNO)
-5,487 -3,523 -4,334 -4,375 -5,916 -4,212 -3,272 -4,359 -4,699 -3,665 -3,842
Total Depreciation and Amortization (D&A)
23 24 40 50 50 52 53 59 55 54 46
Debt-free, Cash-free Net Working Capital to Revenue
9.83% -308.21% -348.16% -328.45% -420.93% -298.54% -227.88% -278.70% -287.58% -221.74% -224.45%
Debt-free Net Working Capital to Revenue
517.12% 33.90% 35.21% 41.48% 32.52% 34.53% 37.37% 38.41% 39.44% 42.06% 42.88%
Net Working Capital to Revenue
516.54% 33.35% 34.69% 40.98% 32.16% 34.09% 36.94% 37.99% 7.27% 10.61% 12.12%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.06 $0.02 ($0.02) $0.29 $0.05 ($0.01) $0.01 $0.06 $0.09 $0.13 ($1.23)
Adjusted Weighted Average Basic Shares Outstanding
154.25M 155.12M 155.69M 155.30M 156.90M 157.90M 158.10M 157.80M 159.40M 159.90M 159.80M
Adjusted Diluted Earnings per Share
$0.06 $0.02 ($0.02) $0.29 $0.04 ($0.01) $0.01 $0.07 $0.09 $0.13 ($1.23)
Adjusted Weighted Average Diluted Shares Outstanding
157.70M 157.55M 155.69M 158.50M 159.90M 157.90M 159.70M 160.40M 161.90M 161M 159.80M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
155.03M 155.61M 156.13M 156.60M 157.90M 158.10M 157.70M 158.92M 159.88M 159.69M 160.03M
Normalized Net Operating Profit after Tax (NOPAT)
27 21 19 27 28 9.87 15 20 24 24 21
Normalized NOPAT Margin
7.25% 5.62% 4.91% 6.80% 6.60% 2.33% 3.31% 4.29% 5.02% 5.06% 4.43%
Pre Tax Income Margin
7.66% 5.36% 3.31% 8.88% 4.26% 0.00% 4.16% 0.19% 3.96% 8.24% -31.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.09 3.15 2.40 4.99 2.38 1.00 3.08 1.12 3.42 6.39 -21.82
NOPAT to Interest Expense
1.46 0.51 -0.91 5.60 1.18 0.89 0.26 46.22 3.06 3.31 3.19
EBIT Less CapEx to Interest Expense
1.00 0.07 -1.17 2.06 0.29 -1.39 -0.15 -2.50 -0.39 2.79 -25.73
NOPAT Less CapEx to Interest Expense
-1.63 -2.58 -4.48 2.67 -0.92 -1.50 -2.97 42.59 -0.75 -0.29 -0.72
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 199.45% 255.60% 177.55% -44.86%

Financials Breakdown Chart

Key Financial Trends

Note: The data provided appears to pertain to Dayforce, Inc. (DAY) rather than Ceridian HCM (CDAY). If you intended CDAY data, please share the Ceridian statements and I’ll adjust the analysis accordingly.

Here are high-level trends from the last eight quarters of the Dayforce statements (roughly spanning 2022 through 2025), highlighting potential implications for investors. I’ve organized the bullets with positive items first, then neutral, then negative items.

  • Operational cash flow stays positive in most periods. Examples: Q2 2025 net cash from continuing operating activities ≈ +$99.2M, Q1 2025 ≈ +$49.6M, Q4 2024 ≈ +$81.0M, indicating solid cash generation from core operations over time.
  • Top-line remains in the mid-to-high $400M range with evidence of growth. For example, Q3 2025 revenue ≈ $481.6M, up from prior periods in the mid-$400Ms range, signaling revenue resilience amid fluctuating margins.
  • Gross margin shown as healthy in some periods. Q3 2025 gross profit ≈ $386M on $481.6M revenue, implying a strong gross margin relative to software/SaaS-like offerings; margin has varied across quarters, but the high single-quarter level is notable.
  • Voluntary financing activity provides liquidity support in some quarters. For instance, Q3 2025 includes a positive “Other Financing Activities, net” ≈ +$194.1M and issuance of common equity ≈ +$13.6M, providing additional cash headroom.
  • Net cash from financing activities occasionally adds to liquidity. In several quarters, financing activities contribute cash, helping funding for working capital and investments when operating cash flow is variable.
  • Large restricted cash balance on the balance sheet. In many periods, Restricted Cash runs into the billions (e.g., ≈ $4.4B at Q3 2025), which is cash that is not readily available for day-to-day operations and reduces immediate liquidity there.
  • Significant customer deposits and current deferred revenue create large current liabilities. Customer Deposits around ≈ $4.4B–$4.5B (varies by quarter) and Current Deferred Revenue around tens of millions to low hundreds of millions, indicating substantial deferred obligations that reverse into revenue over time.
  • Debt levels are moderate relative to equity, with a mix of current and noncurrent liabilities. Long-Term Debt and other liabilities are present, but total liabilities are outpaced by equity in several periods, suggesting manageable leverage in some quarters while remaining watchful of future obligations.
  • Quarterly profitability can be volatile due to non-cash items and one-off effects. Net income fluctuates; some quarters show modest profits, while others (e.g., a large negative in Q3 2025) reflect non-cash adjustments or unusual charges that may not reflect ongoing operations.
  • Q3 2025 net income declines sharply (≈ -$196.8M), driven by substantial non-cash adjustments and/or unusual charges. This creates an earnings gap that could raise questions about sustainability of near-term profitability versus ongoing cash generation.
  • Near-term liquidity risk from high current liabilities versus cash on hand. Cash & equivalents ≈ $627M at Q3 2025, while Total Current Liabilities ≈ $5.3B and restricted cash ≈ $4.4B, which can constrain liquidity despite positive operating cash flow in some periods.
05/06/26 10:58 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Ceridian HCM's Financials

When does Ceridian HCM's fiscal year end?

According to the most recent income statement we have on file, Ceridian HCM's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Ceridian HCM's net income changed over the last 8 years?

Ceridian HCM's net income appears to be on a downward trend, with a most recent value of $18.10 million in 2024, falling from -$92.80 million in 2016. The previous period was $54.80 million in 2023.

What is Ceridian HCM's operating income?
Ceridian HCM's total operating income in 2024 was $104.10 million, based on the following breakdown:
  • Total Gross Profit: $812.10 million
  • Total Operating Expenses: $708 million
How has Ceridian HCM's revenue changed over the last 8 years?

Over the last 8 years, Ceridian HCM's total revenue changed from $623.40 million in 2016 to $1.76 billion in 2024, a change of 182.3%.

How much debt does Ceridian HCM have?

Ceridian HCM's total liabilities were at $6.57 billion at the end of 2024, a 0.6% decrease from 2023, and a 17.3% increase since 2017.

How much cash does Ceridian HCM have?

In the past 7 years, Ceridian HCM's cash and equivalents has ranged from $94.20 million in 2017 to $579.70 million in 2024, and is currently $579.70 million as of their latest financial filing in 2024.

How has Ceridian HCM's book value per share changed over the last 8 years?

Over the last 8 years, Ceridian HCM's book value per share changed from 0.00 in 2016 to 16.15 in 2024, a change of 1,614.7%.



Financial statements for NYSE:CDAY last updated on 11/14/2025 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners